Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Pill Causes Major Weight Loss in Eli Lilly Trial’s Results

The company said it planned to seek Food and Drug Administration approval for the drug, orforglipron, before the end of the year.

Gina Kolata
Author: Gina Kolata

Written by

Gina Kolata

in

Clinical Trials, Drugs (Pharmaceuticals), Eli Lilly and Company, GLP-1 RAs (Drug), Obesity, Research
←Cannonball with Wesley Morris: Beyoncé Isn’t Giving Up on America
The Trump-Backed Federal Budget Threatens Black Economic Progress. Here’s How Black Communities Can Reclaim Their Power→

More posts

  • Protesters, leaders push back against DHS over Newark detention facility conditions

  • Goldman and Lander spar hard over Israel

  • Snowflake climbs after Q1 results top expectations, guidance gets a boost

  • Synopsys drops despite better than expected Q2 results, big boost to full-year guidance

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube